Overview

Radiation Toxicity Treatment Market is predicted to value over USD 5 billion by 2028 end with a CAGR of over 5.2% during the forecast period 2022 to 2028.

The rising installations of radiation therapy machines for treating different cancer types has increased radiation toxicity in patients. Furthermore, favourable reimbursements and government policies for cancer treatments has made radiation therapy ore accessible, thereby boosting the radiation toxicity treatment market growth. Moreover, the increased acceptance of factors that are colony stimulated shall boost the proliferation of the market. Additionally, parameters like positive product reviews, financials have bolstered the augmentation of the market. According to the American cancer Society, over 17,35,000 cancer cases were registered in 2018. Such a high prevalence of cancer shall increase the number of patients getting diagnosed with radiation toxicity, thereby propelling the market growth. Radiation toxicity is primarily caused by exposure to radiations in nuclear power plants either intentionally or accidently. With many countries investing in nuclear energy, there has been a rise in the number of nuclear plants, increasing the chances of people getting toxified by radiations, resulting in the augmentation of the market.

Market Segmentation:

By Product
•   Colony Stimulating Factors
•   Potassium Iodide
•   Prussian Blue
•   Diethylenetriamine Pentaacetic Acid
• Others
By Indication

• Acute Radiation Syndrome
o Bone Marrow Syndrome (Hematopoietic)
o Gastrointestinal Syndrome (GI)
o Cardiovascular (CV)
o Central Nervous System (CNS) Syndrome
• Chronic Radiation Syndrome

By Radiation

• Ionizing Radiation
o Alpha Radiation
o Beta Radiation
o Gamma Radiation
• Non-Ionizing Radiation

By End User
•   Hospitals
•   Research & Academic Institutes
By Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

The market is diversified into product, by indication, by radiation, by end user and region. The product segment is fragmented into colony stimulating factors, potassium iodide, prussian blue, diethylenetriamine pentaacetic acid. The end user segment is classified into hospitals, research & academic institutes.

Regional Analysis:

The North America region is predicted to hold the largest radiation toxicity treatment market share during the forecast period owing to increased use of PET and single-photon emission computed tomography scanning machines at diagnostic centres. Furthermore, favourable health coverage policies and stringent regulations have boosted the market growth in the region. The Asia pacific region, on the other hand, is predicted to grow at a substantial rate during the forecast period.

Competitive Landscape:

Some of the key market players are Aeolus Pharmaceuticals, Cantex Pharmaceuticals, Gamida Cell Ltd., Nanotherpautics Inc., NeoStem Inc., Cleveland BioLabs Inc., Osiris Therapeutics Inc., Amgen Inc., Partner Therapeutics, Inc., Novartis AG.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global radiation toxicity treatment market by product, by indication, by radiation, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com